This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.
本发明涉及一组芳香
脲在治疗细胞因子介导的疾病(除癌症外)和蛋白
水解酶介导的疾病(除癌症外)中的用途,以及用于此类治疗的药物组合物。